Stewart J. Baker
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
-
- PI3K/AKT/mTOR signaling in cancer
- Biochemical and Molecular Research
- Protein Kinase Regulation and GTPase Signaling
Papers in
- Genetics 3
- Chronic Lymphocytic Leukemia Research 3
- Virus-based gene therapy research 1
-
- Biochemical and Molecular Research 4
- PI3K/AKT/mTOR signaling in cancer 4
- Co-authors
- DAVID J. PEARSON (1 shared paper)Graham E. M. Sibley (1 shared paper)G. Mark Taylor (1 shared paper)Robert Lambert (1 shared paper)John H. Merrett (1 shared paper)Richard A. Hopkins (1 shared paper)Mark R. Holland (1 shared paper)Joseph A. Martin (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Cancer Research (1 paper)Tetrahedron Letters (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Stewart J. Baker
8 papers receiving 858 citations
Stewart J. Baker's Hit Papers
Peers
Comparison fields: 5 of 71
- Genetics 187
- Molecular Biology 674
- Organic Chemistry 196
- Oncology 171
- Hepatology 37
Countries citing papers authored by Stewart J. Baker
This map shows the geographic impact of Stewart J. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stewart J. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stewart J. Baker more than expected).
Fields of papers citing papers by Stewart J. Baker
This network shows the impact of papers produced by Stewart J. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stewart J. Baker. The network helps show where Stewart J. Baker may publish in the future.
Co-authors
The 25 scholars most cited alongside Stewart J. Baker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The Identification of 2-(1 H -Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2- d ]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer Hit paper breakdown → | 2008 | 681 |
| 2 | 2007 | 87 | |
| 3 | 2012 | 60 | |
| 4 | 2012 | 50 | |
| 5 | 2004 | 39 | |
| 6 | 1996 | 11 | |
| 7 | 2001 | 11 | |
| 8 | The discovery of GDC-0941: A potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer | 2008 | 5 |
About Stewart J. Baker
Stewart J. Baker is a scholar working on Genetics, Molecular Biology, Infectious Diseases, Hepatology and Organic Chemistry, having authored 8 papers that have together received 944 indexed citations. Recurring topics across this work include Biochemical and Molecular Research (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), HIV/AIDS drug development and treatment (2 papers), Cancer Mechanisms and Therapy (1 paper), Cytomegalovirus and herpesvirus research (1 paper), Virus-based gene therapy research (1 paper) and Hepatitis C virus research (1 paper). The work is most often cited by research in Genetics (187 citations), Molecular Biology (674 citations), Organic Chemistry (196 citations), Oncology (171 citations) and Hepatology (37 citations). Stewart J. Baker has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include DAVID J. PEARSON, Graham E. M. Sibley, G. Mark Taylor, Robert Lambert, John H. Merrett, Richard A. Hopkins, Mark R. Holland, Joseph A. Martin, Gareth J. Thomas and Kevin E. B. Parkes. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Cancer Research and Tetrahedron Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.